Business Daily from THE HINDU group of publications
Sunday, Aug 03, 2008
ePaper | Mobile/PDA Version | Audio
Business Daily from THE HINDU group of publications Sunday, Aug 03, 2008 ePaper | Mobile/PDA Version | Audio |
|
|
|
|
|
Corporate
-
Regulatory Bodies & Rulings USFDA nod for Aurobindo's injections Hyderabad, Aug. 2 The US Food and Drug Administration (USFDA) accorded final approval for Aurobindo Pharma Ltd's sterile injectible formulation line. It had also approved two Abbreviated New Drug Applications of the Hyderabad-based company for ceftriaxone injections. The injections are cephalosporin's products under the anti-infective segment. "This is the first product approval of the sterile injectible formulations line unit VI-B, situated in Hyderabad by USFDA," the company said in a release. The unit is Aurobindo's second sterile injectible facility besides the facility of Cephazone joint venture in California, US.- Our BureauMore Stories on : Regulatory Bodies & Rulings | Pharmaceuticals
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
 |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2008, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|